Indication

Hepatitis C Virus Genotype 1

1 clinical trial

1 product

Clinical trial

A Phase IV, Single Arm, Open-Label Study to Determine the Efficacy and Safety of Ledipasvir/Sofosbuvir (LDV/SOF) in Treatment-Naive Alcoholic Subjects With Chronic Genotype 1 Hepatitis C Infection

Status: Completed, Estimated PCD: 2020-08-01

Product